Intra-Cellular Therapies Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Jul '25 Jul 8, 2025	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017
Market Capitalization	24	47	34	41	-	-
Market Cap Growth	37.37%	37.37%	-16.67%	-	-	-
Enterprise Value	-	34	17	23	-	-
PS Ratio	1.05	2.11	1.70	1.47	-	-
PB Ratio	0.34	0.68	0.46	0.56	-	-
P/OCF Ratio	9.87	19.82	-	-	-	-
EV/Sales Ratio	-	1.51	0.84	0.81	-	-
EV/EBITDA Ratio	-	-	-	25.24	-	-
Debt / Equity Ratio	0.05	0.05	-	0.00	0.00	-
Debt / EBITDA Ratio	-	-	-	0.07	-	-
Quick Ratio	1.36	1.36	1.58	1.56	0.67	-
Current Ratio	2.06	2.06	2.64	2.50	1.17	-
Asset Turnover	0.14	0.14	0.13	0.20	-	-
Return on Equity (ROE)	-3.51%	-3.51%	-1.64%	-0.43%	-	-
Return on Assets (ROA)	-1.25%	-1.25%	-0.91%	-0.10%	-	-
Return on Capital (ROIC)	-2.73%	-2.73%	-1.93%	-0.26%	-	-
Earnings Yield	-10.72%	-5.34%	-3.53%	-0.58%	-	-
Earnings Yield	-10.72%	-5.34%	-3.53%	-0.58%	-	-
Buyback Yield / Dilution	-	-	-	-1.27%	-	-

Updated Mar 30, 2022. Source: S&P Global Market Intelligence. Insurance template. Financial Sources.